Richardson DR - Search Results

1

Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells.

Noulsri E, Richardson DR, Lerdwana S, Fucharoen S, Yamagishi T, Kalinowski DS, Pattanapanyasat K. Noulsri E, et al. Among authors: richardson dr. Am J Hematol. 2009 Mar;84(3):170-6. doi: 10.1002/ajh.21350. Am J Hematol. 2009. PMID: 19140186 Free article.

2

Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity.

Chaston TB, Richardson DR. Chaston TB, et al. Among authors: richardson dr. Am J Hematol. 2003 Jul;73(3):200-10. doi: 10.1002/ajh.10348. Am J Hematol. 2003. PMID: 12827659 Free article. Review.

3

The evolution of iron chelators for the treatment of iron overload disease and cancer.

Kalinowski DS, Richardson DR. Kalinowski DS, et al. Among authors: richardson dr. Pharmacol Rev. 2005 Dec;57(4):547-83. doi: 10.1124/pr.57.4.2. Pharmacol Rev. 2005. PMID: 16382108 Review.

4

PCTH: a novel orally active chelator for the treatment of iron overload disease.

Lovejoy DB, Kalinowski D, Bernhardt PV, Richardson DR. Lovejoy DB, et al. Among authors: richardson dr. Hemoglobin. 2006;30(1):93-104. doi: 10.1080/03630260500455367. Hemoglobin. 2006. PMID: 16540421 Review.

5

Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.

Richardson DR, Sharpe PC, Lovejoy DB, Senaratne D, Kalinowski DS, Islam M, Bernhardt PV. Richardson DR, et al. J Med Chem. 2006 Nov 2;49(22):6510-21. doi: 10.1021/jm0606342. J Med Chem. 2006. PMID: 17064069

6

Investigating biological activity spectrum for novel quinoline analogues.

Musiol R, Jampilek J, Kralova K, Richardson DR, Kalinowski D, Podeszwa B, Finster J, Niedbala H, Palka A, Polanski J. Musiol R, et al. Among authors: richardson dr. Bioorg Med Chem. 2007 Feb 1;15(3):1280-8. doi: 10.1016/j.bmc.2006.11.020. Epub 2006 Nov 14. Bioorg Med Chem. 2007. PMID: 17142046

7

Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.

Yu Y, Wong J, Lovejoy DB, Kalinowski DS, Richardson DR. Yu Y, et al. Among authors: richardson dr. Clin Cancer Res. 2006 Dec 1;12(23):6876-83. doi: 10.1158/1078-0432.CCR-06-1954. Clin Cancer Res. 2006. PMID: 17145804 Review.

8

Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity.

Mrkvicková Z, Kovaríková P, Klimes J, Kalinowski D, Richardson DR. Mrkvicková Z, et al. Among authors: richardson dr. J Pharm Biomed Anal. 2007 Mar 12;43(4):1343-51. doi: 10.1016/j.jpba.2006.11.011. Epub 2006 Dec 12. J Pharm Biomed Anal. 2007. PMID: 17166684

9

Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.

Kalinowski DS, Richardson DR. Kalinowski DS, et al. Among authors: richardson dr. Chem Res Toxicol. 2007 May;20(5):715-20. doi: 10.1021/tx700039c. Epub 2007 Apr 3. Chem Res Toxicol. 2007. PMID: 17402750

10

Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.

Kalinowski DS, Yu Y, Sharpe PC, Islam M, Liao YT, Lovejoy DB, Kumar N, Bernhardt PV, Richardson DR. Kalinowski DS, et al. Among authors: richardson dr. J Med Chem. 2007 Jul 26;50(15):3716-29. doi: 10.1021/jm070445z. Epub 2007 Jun 30. J Med Chem. 2007. PMID: 17602603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters